Stay updated on VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial
Sign up to get notified when there's something new on the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page.

Latest updates to the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page
- Check7 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, signaling a minor update to the study record. No other content changes are evident.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page’s display version (Revision) was updated from v3.5.2 to v3.5.3, indicating a site/browser UI update rather than a change to the clinical study information.SummaryDifference0.1%

- Check35 days agoChange DetectedRevision indicator updated to v3.5.2 and removed v3.5.0.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded B-cell chronic lymphocytic leukemia as a condition term on the study page.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check71 days agoChange DetectedFooter revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page.